Improving Outcomes in Heart Failure – Focus on Guideline Adherence and Comorbidities
Published: 29 September 2020
-
Views:
34 -
Likes:
7
-
Views:
34 -
Likes:
7
-
23m 10sPart 2 Optimising RAASi Therapy Through Long-Term Potassium Control Ileana L Piña
-
25m 32sPart 3 Iron Therapy in Heart Failure – Impact on Exercise Capacity and Quality of Life Peter van der Meer
Overview
In this series from the e-SPACE Heart Failure Global Web-Conference, Ileana Piña, Peter van der Meer and Stefan Anker discuss improving outcomes in heart failure with a focus on guideline adherence and comorbidities.
Organised by MedEd Global Solutions and supported by an unrestricted grant from Vifor Pharma
Educational objectives
- Review Pharmacological Treatments That Reduce Mortality and Hospitalisations in Patients With Heart Failure
- Evaluate Adherence to Heart Failure Management Guidelines and Barriers to Optimal Use of Guideline-Recommended Therapy
- Recognise the Importance of Integrated Care of Comorbidities in the Management of Heart Failure Patients
- Assess the Role of Novel Potassium Binders in Optimising Optimal Renin–Angiotensin– Aldosterone System Inhibitor (RAASi) Therapy in Patients With Heart Failure
- Review the Benefits of Treating Iron Deficiency in Heart Failure With Respect to Functional Capacity and Symptomatic Improvement
Symposium Agenda
- Time - Session title and Objective - Speaker(s)
- 20 mins - Improving Outcomes in Patients With Heart Failure – Optimization Through Personalization - Ileana L. Piña, Detroit, MI, USA
- 20 mins - Optimising RAASi Therapy Through Long-Term Potassium Control - Javed Butler, Atlanta, GA, USA
- 20 mins - Iron Therapy in Heart Failure – Impact on Exercise Capacity and Quality of Life - Peter van der Meer, Groningen, The Netherlands
- 25 mins - Interactive Panel Discussion - Stefan Anker & Javed Butler
More from this programme
Part 1
Improving Outcomes in Patients With Heart Failure – Optimization Through Personalization
Part 2
Optimising RAASi Therapy Through Long-Term Potassium Control
Part 3
Iron Therapy in Heart Failure – Impact on Exercise Capacity and Quality of Life
Part 4
Panel Discussion
1 session | |
Panel Discussion | Watch now |
Faculty Biographies
Stefan Anker
Professor of Cardiology
Dr Stefan D Anker, Professor of Cardiology and Cachexia Research, Department of Cardiology, Charité Campus Virchow-Klinikum, Berlin, Germany, and served as the 2012–14 President of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).